Hyperamylasemia is a common complication during lamivudine use. We report a case of a pancreatitis following lamivudine therapy. A careful monitoring of amylase levels during treatment with lamivudine is discussed, mainly in the first weeks, considering the cost of this exam and further complication.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1590/s1413-86702008000400001 | DOI Listing |
Publication Analysis
Top Keywords
lamivudine therapy
8
acute pancreatitis
4
pancreatitis associated
4
lamivudine
4
associated lamivudine
4
therapy chronic
4
chronic hepatitis
4
hepatitis hyperamylasemia
4
hyperamylasemia common
4
common complication
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!